Ingredient
Oligopeptide-4
Oligopeptide-4 is flagged for pregnancy. The concern behind the strongest flag is absorbed into the body and fetal development.
- EGF
- Epidermal Growth Factor
- sh-Oligopeptide-4
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 1 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 1 of 5
- Higher means more likely to sting or redden
Oligopeptide-4 and pregnancy
Caution Advised
- Absorbed into the body
- Fetal development
Oligopeptide-4 is a synthetic peptide designed to mimic epidermal growth factor (EGF), which stimulates cell growth and proliferation. Growth factors play important roles in skin regeneration and repair. While specific studies on topical use during pregnancy are limited, there are theoretical concerns about using growth factors during pregnancy. Growth factors influence cell proliferation and differentiation, which are critical processes during fetal development. Although topical peptides generally have low systemic absorption, the effects of exogenous growth factors during pregnancy have not been well studied. Many dermatologists recommend a cautious approach with growth factor-containing products during pregnancy due to the lack of safety data. No specific regulatory guidance exists from ACOG or the FDA regarding topical growth factor peptides during pregnancy. However, the general principle of avoiding unnecessary bioactive compounds during pregnancy, especially when safety data is limited, leads many healthcare providers to recommend postponing use until after delivery.
Oligopeptide-4 and breastfeeding
Safe to Use
Oligopeptide-4 is a topical peptide with minimal systemic absorption due to its molecular size and structure. Growth factor peptides are large molecules that typically remain on the skin surface. While specific data on breastfeeding is limited, topical peptides are generally considered low risk during lactation due to minimal absorption into the bloodstream. The large molecular size of peptides makes transfer into breast milk unlikely. Most dermatologists consider topical peptides acceptable during breastfeeding. The AAD has not issued specific warnings about topical peptides during breastfeeding. Given the localized action and low absorption profile, this ingredient is generally considered compatible with breastfeeding, though individual consultation with a healthcare provider is always recommended.
Oligopeptide-4 and postpartum
Safe to Use
Oligopeptide-4 can be beneficial for postpartum skin recovery, helping to support skin repair and elasticity. Growth factor peptides may help address skin texture changes and promote healing after pregnancy. There are no safety concerns for postpartum use when not breastfeeding. The anti-aging and skin repair benefits can support overall skin recovery during this period.
Oligopeptide-4 and trying to conceive
Safe to Use
Oligopeptide-4 is a topical peptide with minimal systemic absorption. While it mimics growth factors, topical application results in localized effects on the skin with little to no systemic impact. Most dermatologists consider topical peptides acceptable while trying to conceive, as they have minimal absorption and no known effects on fertility. However, some women prefer to adopt pregnancy-safe routines proactively, in which case simpler alternatives like niacinamide may be preferred. There is no evidence this ingredient affects conception or early pregnancy.
Oligopeptide-4 and PCOS
Safe to Use
Oligopeptide-4 is a growth factor peptide used for skin repair and anti-aging. It does not have hormone-like properties or effects on androgen, estrogen, or insulin pathways. There are no known concerns for women with PCOS using this ingredient topically. Growth factor peptides work on skin cell renewal and do not interact with hormonal systems. The ingredient is considered safe for topical use regardless of hormonal conditions. No studies suggest this peptide affects PCOS or hormonal balance. It's a cosmetic anti-aging ingredient without endocrine effects.
Oligopeptide-4 and general use
Safe to Use
Oligopeptide-4 is a synthetic peptide that mimics epidermal growth factor (EGF), designed to promote cell renewal, collagen production, and skin repair. It's popular in anti-aging skincare for its ability to support skin regeneration. The ingredient is generally well-tolerated with minimal side effects. Peptides are considered safe cosmetic ingredients with low irritation potential. Some theoretical concerns exist about growth factors and cell proliferation, but topical application has limited systemic effects and there's no evidence of harm from cosmetic use. Oligopeptide-4 is approved for cosmetic use in both the EU and US without restrictions. It's widely used in premium anti-aging products and has a good safety profile for topical application.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Oligopeptide-4, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store